Melissa A Clark1,2,3, Miles Ott4, Michelle L Rogers2, Mary C Politi5, Susan C Miller6,7, Laura Moynihan8, Katina Robison3,9, Ashley Stuckey3,9, Don Dizon10. 1. Department of Epidemiology, School of Public Health, Brown University, Providence, RI, USA. 2. Center for Population Health and Clinical Epidemiology, Brown University, Providence, RI, USA. 3. Department of Obstetrics and Gynecology, Warren Alpert Medical School, Brown University, Providence, RI, USA. 4. Department of Mathematics, Augsburg College, Minneapolis, MN, USA. 5. Division of Public Health Sciences, Department of Surgery, Washington University, St. Louis, MO, USA. 6. Department of Health Services, Policy, and Practice, Brown University, Providence, RI, USA. 7. Center for Gerontology and Health Care Research, Brown University, Providence, RI, USA. 8. Brown University, Providence, RI, USA. 9. Program in Women's Oncology, Women & Infants Hospital, Providence, RI, USA. 10. Departments of Hematology and Oncology and Medicine, Massachusetts General Hospital, Boston, MA, USA.
Abstract
OBJECTIVE: We examined the roles of oncology providers in advance care planning (ACP) delivery in the context of a multidisciplinary cancer program. METHODS: Semi-structured interviews were conducted with 200 women with recurrent and/or metastatic breast or gynecologic cancer. Participants were asked to name providers they deemed important in their cancer care and whether they had discussed and/or completed ACP documentation. Evidence of ACP documentation was obtained from chart reviews. RESULTS: Fifty percent of participants self-reported completing an advance directive (AD) and 48.5% had named a healthcare power of attorney (HPA), 38.5% had completed both, and 39.0% had completed neither document. Among women who self-reported completion of the documents, only 24.0% and 14.4% of women respectively had documentation of an AD and HPA in their chart. Completion of an AD was associated with number (adjusted odds ratio [AOR] = 1.49) and percentage (AOR = 6.58) of providers with whom the participant had a conversation about end-of-life decisions. Participants who named a social worker or nurse practitioner were more likely to report having completed an AD. Participants who named at least one provider in common (e.g., named the same oncologist) were more likely to have comparable behaviors related to naming a HPA (AOR = 1.13, p = 0.011) and completion of an AD (AOR = 1.06, p = 0.114). CONCLUSIONS: Despite the important role of physicians in facilitating ACP discussions, involvement of other staff was associated with a greater likelihood of completion of ACP documentation. Patients may benefit from opportunities to discuss ACP with multiple members of their cancer care team.
OBJECTIVE: We examined the roles of oncology providers in advance care planning (ACP) delivery in the context of a multidisciplinary cancer program. METHODS: Semi-structured interviews were conducted with 200 women with recurrent and/or metastatic breast or gynecologic cancer. Participants were asked to name providers they deemed important in their cancer care and whether they had discussed and/or completed ACP documentation. Evidence of ACP documentation was obtained from chart reviews. RESULTS: Fifty percent of participants self-reported completing an advance directive (AD) and 48.5% had named a healthcare power of attorney (HPA), 38.5% had completed both, and 39.0% had completed neither document. Among women who self-reported completion of the documents, only 24.0% and 14.4% of women respectively had documentation of an AD and HPA in their chart. Completion of an AD was associated with number (adjusted odds ratio [AOR] = 1.49) and percentage (AOR = 6.58) of providers with whom the participant had a conversation about end-of-life decisions. Participants who named a social worker or nurse practitioner were more likely to report having completed an AD. Participants who named at least one provider in common (e.g., named the same oncologist) were more likely to have comparable behaviors related to naming a HPA (AOR = 1.13, p = 0.011) and completion of an AD (AOR = 1.06, p = 0.114). CONCLUSIONS: Despite the important role of physicians in facilitating ACP discussions, involvement of other staff was associated with a greater likelihood of completion of ACP documentation. Patients may benefit from opportunities to discuss ACP with multiple members of their cancer care team.
Authors: Anne Walling; Karl A Lorenz; Sydney M Dy; Arash Naeim; Homayoon Sanati; Steven M Asch; Neil S Wenger Journal: J Clin Oncol Date: 2008-08-10 Impact factor: 44.544
Authors: John J You; James Downar; Robert A Fowler; François Lamontagne; Irene W Y Ma; Dev Jayaraman; Jennifer Kryworuchko; Patricia H Strachan; Roy Ilan; Aman P Nijjar; John Neary; John Shik; Kevin Brazil; Amen Patel; Kim Wiebe; Martin Albert; Anita Palepu; Elysée Nouvet; Amanda Roze des Ordons; Nishan Sharma; Amane Abdul-Razzak; Xuran Jiang; Andrew Day; Daren K Heyland Journal: JAMA Intern Med Date: 2015-04 Impact factor: 21.873
Authors: Lindsay A Dow; Robin K Matsuyama; V Ramakrishnan; Laura Kuhn; Elizabeth B Lamont; Laurel Lyckholm; Thomas J Smith Journal: J Clin Oncol Date: 2009-11-23 Impact factor: 44.544
Authors: Catherine N Zivanov; Anne Coogan; Robin R Lane; Sara G Lin; Sarah C Reed; Marc A Robinson; Mohana Karlekar; Lauren S Prescott; Alaina J Brown Journal: J Cancer Educ Date: 2022-08-24 Impact factor: 1.771
Authors: Leah S Millstein; Paula Rosenblatt; Melissa H Bellin; Laura Whitney; Steven R Eveland; Mei Ching Lee; John Allen; Heather L Mutchie; Todd D Becker; John Cagle Journal: Palliat Med Rep Date: 2022-08-08